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==========================

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder known to increase morbidity, mortality, and socioeconomic burden in patients with stroke.\[[@ref1][@ref2][@ref3]\] The prevalence of AF increases steadily with age, with only 2% of patients ≤65 years, while affecting nearly 9% of people ≥65 years.\[[@ref1]\] AF causes disability and cognitive dysfunction (vascular dementia) even in the absence of overt stroke.\[[@ref4]\] Use of oral anticoagulants reduces stroke risk substantially.\[[@ref5]\]

The prevalence of AF in general population is well documented in developed countries, such as in Rotterdam 5.5%, Auckland 0.4% and Northern Manhattan after stratification according to ethnic groups.\[[@ref4][@ref6][@ref7]\] Global prevalence and incidence of AF are low in developing countries compared to developed countries.\[[@ref8]\] In India, the reported burden of AF is largely from few studies.\[[@ref9][@ref10][@ref11]\] About 8% of stroke patients had AF in Trivandrum population-based registry. However, they did not collect information on valvular heart disease.\[[@ref12]\] In central India, in a community-based sample of 4077, 8 (0.19%) were found to have AF. Rheumatic heart disease (RHD) was the most common cause.\[[@ref13]\] Since these studies are either hospital-based and/or do not focus on AF, they may not give the exact burden of AF in stroke patients. Hence, this study was done to evaluate the risk factors, clinical features, and short-term outcomes of stroke in patients with AF.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

This study was a part of the Indian Council of Medical Research (ICMR) funded research project which was conducted from March 25, 2010, to March 25, 2013. The registry was established in two phases. Phase I was feasibility study (1^st^ year of the registry) and Phase II was epidemiological data collection (from March 26, 2011, to March 25, 2013). Data were collected using WHO-STEPS stroke approach from public hospitals, private hospitals (neurologists and neuro-surgeons), general practitioners (GP), physiotherapy centers, scan/imaging centers, and Municipal Corporation (MC).\[[@ref14][@ref15]\] All stroke patients ≥18 years with first-ever stroke between March 25, 2010, and March 25, 2013, were enrolled in this registry. There was the possibility of duplication of cases. To remove duplicate cases, age, gender, address, and contact were matched. A case was considered duplicate if three or more variables were identical. Duplication could occur at any of the four levels given below:

If the patient\'s data were collected from the same center more than onceDuplication with hospital and the scan center of the same siteDuplication with hospital and the scan center, GPDuplication with hospital and MC.

If a patient\'s data were duplicated at any level mentioned above, then the complete hospital form was collected and included in the data analysis.

The study was approved by the Institutional Ethics Committee, and a written informed consent was taken from all the participants. Data about demographic details, diagnosis modalities, and stroke characteristics were collected at the time of admission. For data collection, WHO STEPS stroke approach was followed. Patients were contacted telephonically and by face-to-face interview 28 days after discharge to assess their outcome. The outcome was measured using modified Rankin scale (MRS 0--2: good outcome; 3--6: poor outcome).

Data selected for this study {#sec2-1}
----------------------------

For this particular study, ischemic stroke patient\'s data collected in the stroke registry in Phase-II (from March 26, 2011, to March 25, 2013) from hospitals, general practitioners, and physiotherapy centers were included in the analysis. Due to lack of AF data collected from scan centers and MC centers were excluded from the analysis. The patient is reported to have AF if an electrocardiograph (ECG) done before stroke (old records) or AF documented during hospitalization. In addition, echocardiogram (ECHO) was done where it was indicated by the centers. The research staff verified the information from the patient records.

AF was broadly classified into two categories valvular versus nonvalvular AF:

Valvular atrial fibrillation: AF due to RHDNonvalvular AF: Absence of rheumatic mitral valve disease, a prosthetic heart valve, or mitral valve repair.\[[@ref16]\]

Statistical analysis {#sec2-2}
--------------------

The statistical measures calculated were descriptive statistics, Chi-square test, Fischer\'s exact test, and independent *t*-test. For the comparison of categorical variables, Chi-square test and Fischer exact test were used. For the comparison of continuous variable, independent *t*-test was used. *P* \< 0.05 was considered as statistical significant. Statistical analysis was performed with SPSS version 21 (IBM Corp., Armonk, NY, USA).

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Demography {#sec2-3}
----------

Total number of patients recruited in the registry during 3-year study period was 7199, after excluding duplicate cases and incomplete entries, 6437 remained. Of these, 5629 were recruited within the study period (from March 26, 2011, to March 25, 2013). After excluding patients from scan centers and MC centers (for the lack of details on AF), 1942 patients' data were analyzed. Among them, AF was seen in 203 (10%) \[[Figure 1](#F1){ref-type="fig"}\]. Out of 203, 3% had RHD and rest was related to nonvalvular AF. The patients in AF group were older (AF: 62 ± 14 vs. non-AF: 60 ± 15 years, *P* = 0.01) \[[Table 1](#T1){ref-type="table"}\].

![Patients' recruitment in the study](AIAN-20-289-g001){#F1}

###### 

Comparison of demographic details of stroke patients in atrial fibrillation versus nonatrial fibrillation patients

![](AIAN-20-289-g002)

Clinical features and risk factors {#sec2-4}
----------------------------------

AF patients were more likely have aphasia (AF 137 \[67%\] vs. non-AF 756 \[44%\], *P* \< 0.0001), less likely to have limb weakness (AF 139 \[69%\] vs. non-AF 1330 \[77%\], *P* = 0.02), unsteady gait (AF 63 \[31%\] vs. non-AF 894 \[52%\], *P* \< 0.0001), headache (AF 52 \[26%\] vs. non-AF 623 \[36%\], *P* = 0.005), and facial weakness (AF 57 \[28%\] vs. non-AF 717 \[41%\], *P* \< 0.001) \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of symptoms of stroke patients in atrial fibrillation versus nonatrial fibrillation patients

![](AIAN-20-289-g003)

The higher percentage of AF patients had hypertension (AF 176 \[87%\] vs. non-AF 1396 \[80%\], *P* = 0.03), coronary artery disease (AF 60 \[30%\] vs. non-AF 195 \[11%\], *P* \< 0.0001), carotid stenosis (AF 14 \[7%\] vs. non-AF 57 \[3%\], *P* = 0.02), and hyperlipidemia (AF 60 \[32%\] vs. non-AF 345 \[21%\], *P* = 0.001) but fewer consumed alcohol (AF 15 \[7%\] vs. non-AF 248 \[14%\], *P* = 0.005) \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of risk factors of stroke in patients with atrial fibrillation versus nonatrial fibrillation

![](AIAN-20-289-g004)

Outcome {#sec2-5}
-------

At 28 days, it was possible to contact patients telephonically. In AF group, 182 (89.7%) patients were contacted and 1504 (86.5%) patients in non-AF group. Patients in AF group had worse outcome (mRs \>2: AF 90 \[50%\] vs. non-AF 555 \[37%\], *P* = 0.001) \[[Figure 2](#F2){ref-type="fig"}\].

![Outcome of patients in stroke patients in atrial fibrillation and nonatrial fibrillation at 28 days using modified Rankin scale](AIAN-20-289-g005){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Ten percent of stroke patients had AF. They were older, were more likely to present with aphasia, had multiple risk factors, and worse short-term outcome.

AF as a risk factor of stroke was comparable with other hospital-based studies from Pakistan (7% and 12%)\[[@ref17][@ref18]\] and Nepal (13.8%).\[[@ref19]\] Indian Heart Rhythm Society (IHRS-AF) conducted India\'s first AF registry. In this study, the average age was 54 years, but in the current study, AF patients were older. In IHRS-AF, RHD was the most common cause (732/1537 or 47.6%) followed by hypertension 482 (31.4%), heart failure 288 (18.7%), diabetes mellitus 248 (16.1%), and hyperlipidemia 131 (8.53%).\[[@ref20]\] These risk factors were similar to the current study except for fewer RHD patients. Stroke patients with AF have multiple risk factors, and stroke mechanism (s) could be undetermined in these patients. However, certain imaging characteristics such as large artery occlusion or multiple infarcts in different territories may indicate AF as a mechanism in this group. It is important to recognize all risk factors in stroke patients with AF because stroke is multifactorial and other factors (apart from AF) will continue to be active. Hence, each factor needs to be recognized and addressed individually. These risk factors are also reported as common by other series from Pakistan and Nepal.\[[@ref19][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26]\]

Patients in AF group had worse outcome when compared to patients in non-AF group. These findings are similar to reported studies that establish stroke in AF patients to be more severe and have worse outcome compared to stroke patients without AF.\[[@ref1][@ref27][@ref28][@ref29][@ref30][@ref31]\] AF patients usually have large clot burden or occlusion of major vessels. However, in the current study, we did not collect information regarding the volume of infarct and vessel status.

The strength of this study is that it had population-based cohort which provides a more precise burden of AF in stroke patients.

There are a few limitations of this study. First, in this study, the general population was not screened to find out the burden of AF in the community. Second, we did not collect information about single or serial ECGs and also about Holter monitoring. Since ECHO and repeat ECGs were not done in all the patients, AF may be underestimated.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

Ten percent of stroke patients had AF. AF patients in this cohort were older with multiple risk factors for stroke and had worse outcome. There was no gender difference seen in this large cohort.
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